Prof. John Martin
Academic Board Member
John Martin studied philosophy in Spain before qualifying from Sheffield University Medical School in 1973. He became a senior lecturer at Melbourne University , Australia where he began his research into platelet formation.In 1986 he set up a unique arrangement combining an academic clinical career, at King's College School of Medicine, with the post of Head of Cardiovascular Research at the Wellcome Foundation Research Laboratories.
In 1990 he became the British Heart Foundation Professor of Cardiovascular Science and moved this Chair to UCL in 1996. He now directs the Centre. He is on the Board of the European Society of Cardiology and is past Vice-President. He wrote the "Heart Plan for Europe ", which gave rise to a statement from the Council of Ministers of the European Union in June 2002. He served on the Home Office Animal Procedures Committee from 1998 to 2006. He is Chairman of the British Collaborative on Stem Cells and Repair of the Heart, and the ESC Task Force on Stem Cells in the Heart. See also Cardiovascular Chairs.
John Martin is the Chairman of the Exploitation Committee of the European Vascular Genomics Network (EVGN)
His research interest in platelet biology on pathophysiology continues. Recently he has been involved in the novel role of VEGF as an arterioprotective agent. As a clinician at University College Hospitals Trust he is involved in human pathophysiological studies, particularly on the role of platelets in arterial thrombosis.
He is founder of the biotechnology company, Ark Therapeutics, which has laboratories in UK and Finland. He is a member of the executive committe of the European Vascular Genomics Network.